Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

90 minutes of exercise after vaccination may provide an extra immune boost

Researchers at Iowa State University found 90 minutes of mild- to moderate-intensity exercise directly after a flu or COVID-19 vaccine may provide an extra immune boost.

12 Feb 2022

SARS-CoV-2 nucleocapsid G215C variation may explain Delta severity

A new study shows that the SARS-CoV-2 nucleocapsid protein has unique properties that allow the virus to become more infective in the presence of certain mutations.

11 Feb 2022

Case study: COVID-19 preventive behaviors impacted by implicit social pressure, desire for normalcy

As we move into the third year of the COVID-pandemic, we still face a multitude of information and it can be hard to know what guidelines to follow.

10 Feb 2022

Spillover of SARS-CoV-2 Omicron variant infection in white-tailed deer in New York

Researchers detected evidence for SARS-CoV-2 Omicron variant exposure in the white-tailed deer population inhabiting Staten Island in New York.

10 Feb 2022

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

In two recent studies, researchers at Washington University School of Medicine in St. Louis found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants — at least in rodents — but that many antibody-based therapies may not be effective against it.

10 Feb 2022

Study tests efficacy of molnupiravir against SARS-CoV-2 VOCs in various animal models

A study published on the bioRxiv* preprint server evaluates molnupiravir against a panel of relevant VOCs using three efficacy models: primary human airway epithelium organoids, a ferret model of upper respiratory disease, and a Roborovski dwarf hamster model for severe COVID-19.

9 Feb 2022

Wearable devices can help monitor wellness during recovery from COVID-19

Researchers compare the resting heart changes in individuals with COVID-19 with individuals diagnosed with seasonal influenza.

9 Feb 2022

How SARS-CoV-2 infection progresses throughout the respiratory system

Researchers discuss the progression of SARS-CoV-2 infection throughout the respiratory epithelium.

9 Feb 2022

New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

The novel coronavirus, or SARS-CoV-2, which causes the highly contagious COVID-19, has infected millions of people worldwide.

9 Feb 2022

Exploring omicron infection in COVID-19 vaccinated and convalescent South African healthcare workers

In a new study, researchers evaluated healthcare workers in South Africa, presenting with SARS-CoV-2 symptoms, for infection by the Omicron variant.

9 Feb 2022

Implications of the SARS-CoV-2 pandemic on influenza epidemics

A new study investigated the effect of low circulating seasonal influenza virus during the SARS-CoV-2 pandemic on the antibody titers against influenza during the same period.

9 Feb 2022

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Researchers assessed the intensity of association between SARS-CoV-2 infection and risks of various respiratory and non-respiratory complications.

9 Feb 2022

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury and the risk of blood clots in severe COVID-19 and other disorders that cause immune-mediated damage to the lungs, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.

8 Feb 2022

FDA-approved drug prevents the immune system from producing neutrophil extracellular traps

A team of scientists led by Cold Spring Harbor Laboratory (CSHL) have discovered that disulfiram, an FDA-approved drug, prevents the immune system from producing toxic webs known as neutrophil extracellular traps (NETs).

8 Feb 2022

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

Mycology and immunology researchers from The University of Texas at San Antonio have been selected to receive a five-year, $6.8 million grant from the National Institutes of Health to establish a San Antonio-based Coccidioidomycosis Collaborative Research Center (SA-CCRC) focused on developing therapeutics and vaccines against coccidioidomycosis.

8 Feb 2022

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

90 minutes of exercise after vaccination may provide an extra immune boost

SARS-CoV-2 nucleocapsid G215C variation may explain Delta severity

Case study: COVID-19 preventive behaviors impacted by implicit social pressure, desire for normalcy

Spillover of SARS-CoV-2 Omicron variant infection in white-tailed deer in New York

Omicron resists antibodies, causes less severe disease than previous SARS-CoV-2variants

Study tests efficacy of molnupiravir against SARS-CoV-2 VOCs in various animal models

Wearable devices can help monitor wellness during recovery from COVID-19

How SARS-CoV-2 infection progresses throughout the respiratory system

New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

Exploring omicron infection in COVID-19 vaccinated and convalescent South African healthcare workers

Implications of the SARS-CoV-2 pandemic on influenza epidemics

Association between SARS-CoV-2 infection and several key respiratory and non-respiratory complications

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

FDA-approved drug prevents the immune system from producing neutrophil extracellular traps

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

Study explores SARS-CoV-2 manifestations and related hospitalizations in infants

Exploring the high incidence of croup in children during the SARS-CoV-2 Omicron wave

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

Missouri’s war on public health shows extent of national rift

Impact of SARS-CoV-2 infection in pregnant women on maternal and perinatal outcomes

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in